摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Ethyl 2-[[3-[3-[3-[bis(2-ethoxy-2-oxoethyl)amino]-2-hydroxypropoxy]-2,2-bis[[3-[bis(2-ethoxy-2-oxoethyl)amino]-2-hydroxypropoxy]methyl]propoxy]-2-hydroxypropyl]-(2-ethoxy-2-oxoethyl)amino]acetate | 914111-61-8

中文名称
——
中文别名
——
英文名称
Ethyl 2-[[3-[3-[3-[bis(2-ethoxy-2-oxoethyl)amino]-2-hydroxypropoxy]-2,2-bis[[3-[bis(2-ethoxy-2-oxoethyl)amino]-2-hydroxypropoxy]methyl]propoxy]-2-hydroxypropyl]-(2-ethoxy-2-oxoethyl)amino]acetate
英文别名
——
Ethyl 2-[[3-[3-[3-[bis(2-ethoxy-2-oxoethyl)amino]-2-hydroxypropoxy]-2,2-bis[[3-[bis(2-ethoxy-2-oxoethyl)amino]-2-hydroxypropoxy]methyl]propoxy]-2-hydroxypropyl]-(2-ethoxy-2-oxoethyl)amino]acetate化学式
CAS
914111-61-8
化学式
C49H88N4O24
mdl
——
分子量
1117.25
InChiKey
SXDILZYDFARCEE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.3
  • 重原子数:
    77
  • 可旋转键数:
    56
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.84
  • 拓扑面积:
    341
  • 氢给体数:
    4
  • 氢受体数:
    28

反应信息

点击查看最新优质反应信息

文献信息

  • [DE] VERWENDUNG VON SUBSTITUIERTEN 2-PHENYLBENZIMIDAZOLEN ALS ARZNEIMITTEL<br/>[EN] USE OF SUBSTITUTED 2-PHENYLBENZIMIDAZOLES AS MEDICAMENTS<br/>[FR] UTILISATION DE 2-PHENYLBENZIMIDAZOLES SUBSTITUES EN TANT QUE MEDICAMENTS
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2004062663A1
    公开(公告)日:2004-07-29
    Die vorliegende Erfindung betrifft die Verwendung eines substituierten 2-Phenylbenzimidazols der Formel (I), worin R1, R2, R3, R4, R5 und m die in den Ansprüchen angegebenen Bedeutungen aufweisen, für die Herstellung eines Medikamentes zur Behandlung oder Vorbeugung von Krankheiten, bei denen Glucagon Rezeptoren beteiligt sind, sowie neue Verbindungen der Formel (I), worin R1 ein Dehydroabietyl-Rest der Formel (II) ist.
    这项发明涉及使用式(I)的取代2-苯基苯并咪唑,其中R1、R2、R3、R4、R5和m具有权利要求中所述的含义,用于制备一种药物,用于治疗或预防涉及胰高血糖素受体的疾病,以及式(I)中R1为式(II)的脱氢松香烯基团的新化合物。
  • DIVERGENT SYNTHESIS OF LOOPED POLY(ESTER)-AND POLY(ETHER)-SUBSTITUTED DENDRONS AND DENDRIMERS
    申请人:Tomalia Donald A.
    公开号:US20100086482A1
    公开(公告)日:2010-04-08
    The present invention describes a process for preparing new looped dendrimer and dendron compounds by controlling the molar amount of branch cell reagent monomer that is combined with various cores bearing core-XR functionalities (e.g., primary, or secondary amines, thiol, or epoxy functionalities). These looped, macrocyclic structures are more robust to various conditions, with greater resistance to acid/base hydrolysis. Alternatively, the looped, macrocyclic structure may offer new orientations that would qualify it as a better chelation ligand for metals, and other similar uses.
    本发明描述了一种通过控制与带有核心-XR功能基团(例如,主要或次要胺基,硫醇或环氧基团)的各种核心结构相结合的支链细胞试剂单体的摩尔量来制备新的环形树状分子和树状化合物的过程。这些环形的大环结构在各种条件下更加稳健,对酸碱水解有更强的抵抗力。另外,这种环形的大环结构可能提供新的取向,使其成为更好的金属螯合配体以及其他类似用途的合适选择。
  • Nouveau procédé de synthèse de l'acide (2S, 3aS, 7aS)-perhydroindole-2-carboxilique et de ses esters, et application à la synthèse du perindopril
    申请人:Les Laboratoires Servier
    公开号:EP1354875A1
    公开(公告)日:2003-10-22
    Procédé de synthèse industrielle de dérivés de formule (I) : dans laquelle R représente un atome d'hydrogène ou un groupement benzyle ou alkyle (C1-C6) linéaire ou ramifié, ainsi que leurs sels d'addition à un acide ou à une base minéral(e) ou organique. Application à la synthèse du perindopril et de ses sels pharmaceutiquement acceptables.
    式(I)衍生物的工业合成工艺 其中 R 代表氢原子或苄基或直链或支链(C1-C6)烷基、 及其与无机或有机酸或碱的加成盐。 应用于培哚普利及其药用盐的合成。
  • Dendritic Polymers With Enhanced Amplification and Interior Functionality
    申请人:Tomalia A. Donald
    公开号:US20070298006A1
    公开(公告)日:2007-12-27
    Dendritic polymers with enhanced amplification and interior functionality are disclosed. These dendritic polymers are made by use of fast, reactive ring-opening chemistry (or other fast reactions) combined with the use of branch cell reagents in a controlled way to rapidly and precisely build dendritic structures, generation by generation, with cleaner chemistry, often single products, lower excesses of reagents, lower levels of dilution, higher capacity method, more easily scaled to commercial dimensions, new ranges of materials, and lower cost. The dendritic compositions prepared have novel internal functionality, greater stability (e.g., thermal stability and less or no reverse Michael's reaction), and reach encapsulation surface densities at lower generations. Unexpectedly, these reactions of polyfunctional branch cell reagents with polyfunctional cores do not create cross-linked materials. Such dendritic polymers are useful as demulsifiers for oil/water emulsions, wet strength agents in the manufacture of paper, proton scavengers, polymers, nanoscale monomers, calibration standards for electron microscopy, making size selective membranes, and agents for modifying viscosity in aqueous formulations such as paint. When these dendritic polymers have a carried material associated with their surface and/or interior, then these dendritic polymers have additional properties for carrying materials due to the unique characteristics of the dendritic polymer, such as for drug delivery, transfection, and diagnostics.
  • PEHAM Dendrimers for Use in Agriculture
    申请人:Hayes Ryan T.
    公开号:US20110230348A1
    公开(公告)日:2011-09-22
    Specific PEHAM dendrimers are used in a formulation with an active agent for agricultural purposes, particularly for increasing the efficacy of the active agent in various ways, such as by improving solubility of the active agent in the formulation, by improving adhesion and penetration of the active agent to plant surfaces, by improving the water-fastness of the active agent to the plant or seed, by increasing soil penetration of the active agent to reach the plant roots or under soil parts, or by reducing soil adhesion of the active agent to reach the plant roots or under soil parts, or reducing enzymatic degradation of the active agent by the plant or seed or microorganisms in the soil.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物